23andMe previously raised $22m in its series C round from a consortium including new investor Johnson & Johnson Development Corporation and has added $9m from MPM Capital.

Venture capital firm MPM Capital has joined a syndicate investing a further $9m in US-based personal genetics research company 23andMe.

23andMe previously raised $22m in its series C round from a consortium including new investor Johnson & Johnson Development Corporation (JJDC), the corporate venturing unit of a local healthcare company.

Alongside JJDC in the syndicate were repeat investors Google Ventures, the corporate venturing unit of search engine firm Google, and venture capital (VC) firm New Enterprise Associates (NEA). Google…